OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based intratumoral cancer immunotherapy, has appointed Dr. Soldano Ferrone, M.D., Ph.D., to the company’s Scientific Advisory Board.
from Content Keyword RSS http://ift.tt/1rxtp10
via IFTTT
from Content Keyword RSS http://ift.tt/1rxtp10
via IFTTT
No comments:
Post a Comment